A3P Biomedical specializes in advanced prostate cancer diagnostics with the main product Stockholm3, providing a more precise test and clearer results for the patient. The company’s mission is to improve the quality of life of men by radically increasing the precision in prostate cancer diagnostics. A total of SEK 750 million has been invested in clinical studies and product development for Stockholm3. The company headquarters is located in Stockholm with around 30 employees.